Skip to main content
Erschienen in: Notfall +  Rettungsmedizin 4/2005

01.06.2005 | Schwerpunkt: Neurologische Notfälle

Schlaganfall

verfasst von: PD Dr. M. Eicke

Erschienen in: Notfall + Rettungsmedizin | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Schlaganfall ist mittlerweile eine behandelbare Erkrankung geworden. Pharmakologische Ansätze wie die Thrombolyse mit rt-PA, aber auch fundiertere Kenntnisse zu den erforderlichen Basismaßnahmen eröffnen insbesondere bei der Ischämie neue therapeutische Möglichkeiten. Aber das Zeitfenster ist eng, Transport in die Klinik und erste diagnostische Maßnahmen sollten spätestens 3 h nach Beginn der Symptomatik abgeschlossen sein: „time is brain!“ Doch nach wie vor geht zu viel Zeit verloren durch eine zu späte Verständigung des Rettungsdienstes oder durch unzureichende Logistik im Krankenhaus. Stroke Units sind in allen Bundesländern etabliert und haben sich auf die Behandlung des akuten Schlaganfall spezialisiert. Eine enge lokale und regionale Kooperation von Rettungsdiensten und Krankenhäusern sowie eine gute Aufklärungsarbeit der Bevölkerung sind erforderlich, um im Ernstfall einen reibungslosen und schnellen Ablauf zu gewährleisten.
Literatur
1.
Zurück zum Zitat Arboix A, Massons J, Oliveres M, Arribas MP, Titus F (1994) Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalalgia 14: 37–40CrossRefPubMed Arboix A, Massons J, Oliveres M, Arribas MP, Titus F (1994) Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalalgia 14: 37–40CrossRefPubMed
2.
Zurück zum Zitat Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K (1994) Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 25: 951–957PubMed Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K (1994) Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 25: 951–957PubMed
3.
Zurück zum Zitat Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282: 2019–2026CrossRefPubMed Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282: 2019–2026CrossRefPubMed
4.
Zurück zum Zitat Collins R, MacMahon S (1994) Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 50: 272–298PubMed Collins R, MacMahon S (1994) Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 50: 272–298PubMed
5.
Zurück zum Zitat Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC (1995) Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26: 21–24PubMed Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC (1995) Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26: 21–24PubMed
6.
Zurück zum Zitat Frank JI (1995) Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 45: 1286–1290 Frank JI (1995) Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 45: 1286–1290
7.
Zurück zum Zitat Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996) ‚Malignant‘ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53: 309–315 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996) ‚Malignant‘ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53: 309–315
8.
Zurück zum Zitat Hacke W, Albers G, Al-Rawi Y et al.; DIAS Study Group (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial withvintravenous desmoteplase. Stroke 36: 66–73CrossRefPubMed Hacke W, Albers G, Al-Rawi Y et al.; DIAS Study Group (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial withvintravenous desmoteplase. Stroke 36: 66–73CrossRefPubMed
9.
Zurück zum Zitat Holtkamp M, Buchheim K, Unterberg A, Hoffmann O, Schielke E, Weber JR, Masuhr F (2001) Hemicraniectomy in elderly patients with space occupying media infarction: improved survival but poor functional outcome. J Neurol Neurosurg Psychiatry 70: 226–228 Holtkamp M, Buchheim K, Unterberg A, Hoffmann O, Schielke E, Weber JR, Masuhr F (2001) Hemicraniectomy in elderly patients with space occupying media infarction: improved survival but poor functional outcome. J Neurol Neurosurg Psychiatry 70: 226–228
10.
Zurück zum Zitat Hutchinson PJ, Seeley HM, Kirkpatrick PJ (1998) Factors implicated in deaths from subarachnoid haemorrhage: are they avoidable? Br J Neurosurg 12: 37–40 Hutchinson PJ, Seeley HM, Kirkpatrick PJ (1998) Factors implicated in deaths from subarachnoid haemorrhage: are they avoidable? Br J Neurosurg 12: 37–40
11.
Zurück zum Zitat Inao S, Kuchiwaki H, Wachi A, Andoh K, Nagasaka M, Sugita K, Furuse M (1990) Effect of mannitol on intracranial pressure-volume status and cerebral haemodynamics in brain oedema. Acta Neurochir Suppl (Wien) 51: 401–403 Inao S, Kuchiwaki H, Wachi A, Andoh K, Nagasaka M, Sugita K, Furuse M (1990) Effect of mannitol on intracranial pressure-volume status and cerebral haemodynamics in brain oedema. Acta Neurochir Suppl (Wien) 51: 401–403
12.
Zurück zum Zitat Kase C, Mohr JP, Caplan LR (1998) Intracerebral hemorrhage. In: Barnett HJM, Stein B, Yatsu F, Mohr JP (eds) Stroke: pathophysiology, diagnosis, and management. Churchill Livingstone, New York Philadelphia, pp 649–670 Kase C, Mohr JP, Caplan LR (1998) Intracerebral hemorrhage. In: Barnett HJM, Stein B, Yatsu F, Mohr JP (eds) Stroke: pathophysiology, diagnosis, and management. Churchill Livingstone, New York Philadelphia, pp 649–670
13.
Zurück zum Zitat Kolominsky-Rabas PL, Sarti C, Heuschmann PU et al. (1998) A prospective community-based study of stroke in Germany — the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 29: 2501–2506PubMed Kolominsky-Rabas PL, Sarti C, Heuschmann PU et al. (1998) A prospective community-based study of stroke in Germany — the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 29: 2501–2506PubMed
14.
Zurück zum Zitat Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Europe/AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36: 74–79CrossRefPubMed Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Europe/AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36: 74–79CrossRefPubMed
15.
Zurück zum Zitat Mendelow AD, Gregson BA, Fernandes HM et al. (2005) STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral haemorrhage (STICH): a randomised trial. Lancet 365: 387–397PubMed Mendelow AD, Gregson BA, Fernandes HM et al. (2005) STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral haemorrhage (STICH): a randomised trial. Lancet 365: 387–397PubMed
16.
Zurück zum Zitat Prospective studies collaboration (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346: 1647–1653CrossRefPubMed Prospective studies collaboration (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346: 1647–1653CrossRefPubMed
17.
Zurück zum Zitat Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347: 422–425CrossRefPubMed Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347: 422–425CrossRefPubMed
18.
Zurück zum Zitat Ropper AH, Shafran B (1984) Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 41: 26–29 Ropper AH, Shafran B (1984) Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 41: 26–29
19.
Zurück zum Zitat Schwab S, Schwarz S, Aschoff A, Keller E, Hacke W (1998) Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction. Acta Neurochir Suppl 71: 131–134PubMed Schwab S, Schwarz S, Aschoff A, Keller E, Hacke W (1998) Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction. Acta Neurochir Suppl 71: 131–134PubMed
20.
Zurück zum Zitat Schrader J, Luders S, Kulschewski A et al.; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group (2003) The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34: 1699–1703CrossRefPubMed Schrader J, Luders S, Kulschewski A et al.; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group (2003) The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34: 1699–1703CrossRefPubMed
21.
Zurück zum Zitat Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W (1998) Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 29: 1888–1893PubMed Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W (1998) Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 29: 1888–1893PubMed
22.
Zurück zum Zitat The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1587CrossRefPubMed The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1587CrossRefPubMed
23.
Zurück zum Zitat Trust Study Group (1990) Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336: 1205–1209CrossRefPubMed Trust Study Group (1990) Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336: 1205–1209CrossRefPubMed
24.
Zurück zum Zitat Wannamethee SG, Shaper AG, Whincup PH, Walker M (1995) Smoking cessation and the risk of stroke in middle-aged men. JAMA 274: 155–160CrossRefPubMed Wannamethee SG, Shaper AG, Whincup PH, Walker M (1995) Smoking cessation and the risk of stroke in middle-aged men. JAMA 274: 155–160CrossRefPubMed
25.
Zurück zum Zitat Weimar C, Ziegler A, König IR, Diener HC (2002) Predicting functional outcome and survival after acute ischemic stroke. J Neurol 249: 888–895CrossRefPubMed Weimar C, Ziegler A, König IR, Diener HC (2002) Predicting functional outcome and survival after acute ischemic stroke. J Neurol 249: 888–895CrossRefPubMed
26.
Zurück zum Zitat Weir CJ, Murray GD, Dyker AG, Lees KR (1997) Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314: 1303–1306PubMed Weir CJ, Murray GD, Dyker AG, Lees KR (1997) Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314: 1303–1306PubMed
27.
Zurück zum Zitat Williams LS, Rotich J, Qi R et al. (2002) Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59: 67–71 Williams LS, Rotich J, Qi R et al. (2002) Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59: 67–71
Metadaten
Titel
Schlaganfall
verfasst von
PD Dr. M. Eicke
Publikationsdatum
01.06.2005
Verlag
Springer-Verlag
Erschienen in
Notfall + Rettungsmedizin / Ausgabe 4/2005
Print ISSN: 1434-6222
Elektronische ISSN: 1436-0578
DOI
https://doi.org/10.1007/s10049-005-0736-4

Weitere Artikel der Ausgabe 4/2005

Notfall +  Rettungsmedizin 4/2005 Zur Ausgabe

Schwerpunkt: Neurologische Notfälle

Guillain-Barré-Syndrom

Schwerpunkt: Neurologische Notfälle

Status epilepticus

Schwerpunkt: Neurologische Notfälle

Notfälle bei extrapyramidalen Erkrankungen

Schwerpunkt: Neurologische Notfälle

Der nichttraumatische spinale Notfall